Literature DB >> 25916204

Effects of butafosfan with or without cyanocobalamin on the metabolism of early lactating cows with subclinical ketosis.

U Nuber1, H A van Dorland1, R M Bruckmaier1.   

Abstract

Fifty-one dairy cows with subclinical ketosis were used to investigate the effects of butafosfan alone or in combination with cyanocobalamin on metabolism. Treatments included i.v. injection of 10 ml/100 kg of body weight with butafosfan (BUT) or combined cyanocobalamin with butafosfan (BUTCO) at a similar concentration as in Catosal(®) . Control cows (CON) received a 0.9% saline solution. Cows were injected on days 1-3 at 22.3 ± 0.7 days post-partum. Milk production and composition were not affected by the treatments. In plasma, CON cows had a significantly higher plasma NEFA concentration (0.59 ± 0.03 mm) across the study period than BUTCO cows (p < 0.05; 0.42 ± 0.03 mm), whereas the plasma NEFA concentration of BUT was intermediate (0.52 ± 0.03 mm) but not significantly different from CON. Both BUTCO and BUT cows had lower (p < 0.05) plasma BHBA concentrations (1.02 ± 0.06 mm and 1.21 ± 0.06 mm, respectively) across the study period than CON (1.34 ± 0.06 mm). Plasma glucose was not different between treatments, but plasma glucagon concentrations were consistently high in BUT compared to BUTCO and CON. Lowest post-treatment glucagon levels were observed in BUTCO. Hepatic mRNA abundance of liver X receptor α, a nuclear receptor protein involved in lipid metabolism, was higher in BUTCO compared to BUT and CON (p < 0.05) on day 7. Furthermore, on day 7, the mRNA abundance of beta-hydroxybutyrate dehydrogenase 2 was higher in BUTCO compared to BUT and CON (p < 0.01). In conclusion, injections of combined cyanocobalamin with butafosfan post-partum in early lactation ketotic dairy cows act on lipid metabolism with effects on plasma metabolites, most likely mediated via modified activity of key factors in the liver. Results indicate that the application of butafosfan only in combination with cyanocobalamin exhibits the expected positive effects on metabolism. Journal of Animal Physiology and Animal Nutrition
© 2015 Blackwell Verlag GmbH.

Entities:  

Keywords:  butafosfan; cyanocobalamin; glucagon; liver; metabolism

Mesh:

Substances:

Year:  2015        PMID: 25916204     DOI: 10.1111/jpn.12332

Source DB:  PubMed          Journal:  J Anim Physiol Anim Nutr (Berl)        ISSN: 0931-2439            Impact factor:   2.130


  3 in total

1.  Sarcoptes infestation in two miniature pigs with zoonotic transmission - a case report.

Authors:  Alexander Grahofer; Jeanette Bannoehr; Heiko Nathues; Petra Roosje
Journal:  BMC Vet Res       Date:  2018-03-13       Impact factor: 2.741

2.  Butaphosphan Effects on Glucose Metabolism Involve Insulin Signaling and Depends on Nutritional Plan.

Authors:  Maria Amélia Agnes Weiller; Joao Alveiro Alvarado-Rincón; Carolina Bespalhok Jacometo; Carlos Castilho Barros; Izabel Cristina Custódio de Souza; Lucas Teixeira Hax; Thaís Casarin da Silva; Patrícia Mattei; Antônio Amaral Barbosa; Josiane de Oliveira Feijó; Rubens Alves Pereira; Cassio Cassal Brauner; Viviane Rohrig Rabassa; Francisco Augusto Burkert Del Pino; Marcio Nunes Corrêa
Journal:  Nutrients       Date:  2020-06-22       Impact factor: 5.717

3.  Effects of intravenous butaphosphan and cyanocobalamin to late pregnant ewes on the metabolic indices around parturition and weight gain of their lambs after birth.

Authors:  Azizollah Mohammadi Barimanloo; Aliasghar Chalmeh; Mehrdad Pourjafar; Abdolah Mirzaei
Journal:  Vet Med Sci       Date:  2021-12-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.